Unlike the patients previously reported with TMEM126A-associated OPA7 [5,6], who presented with onset during childhood (between age 4 and 6, and from birth, respectively), and with a severe phenotype, the patients described here presented with a later onset and milder form without apparent cardiac symptoms or hearing defect [6]. This evidence concerns the gene TMEM126A and Hearing impairment.